PMID:21905786: Difference between revisions
New PMID: Page! |
Fill PMID: Page! |
||
| Line 1: | Line 1: | ||
{{RightTOC}} | |||
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.183594.M53a64407c21b6--> | |||
<!-- | |||
****************************************************************************************** | |||
* | |||
* ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | |||
* | |||
****************************************************************************************** --> | |||
{| id="M53a64407c21b6" class=" tableEdit PMID_info_table" | |||
|- | |||
!align=left |Citation | |||
|| | |||
'''Burrowes, B, Harper, DR, Anderson, J, McConville, M and Enright, MC''' (2011) Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. ''Expert Rev Anti Infect Ther'' '''9''':775-85 | |||
|- | |||
!align=left |Abstract | |||
|| | |||
The use of bacteriophages (phages) to treat bacterial infections, known as phage therapy, has a history substantially longer than that of antibiotics, yet these drugs have been the treatment of choice in the West for over 60 years owing to efficacy, low toxicity and ease of production. Bacteria are becoming increasingly resistant to antibiotics while efforts to discover new agents have drastically reduced. Phages have co-evolved with their hosts over billions of years and have acquired mechanisms to counter bacterial defences such as extracellular biofilm production, which severely reduces the effectiveness of conventional antibiotics. Recent animal and human trials show phages to be safe, well-tolerated agents with a bright future as an alternative to chemical agents. | |||
|- | |||
!align=left |Links | |||
|| | |||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=21905786 PubMed] | |||
Online version:[http://dx.doi.org/10.1586/eri.11.90 10.1586/eri.11.90] | |||
|- | |||
!align=left |Keywords | |||
|| | |||
Anti-Bacterial Agents/therapeutic use; Bacterial Infections/microbiology; Bacterial Infections/therapy; Bacteriophages/pathogenicity; Biofilms/drug effects; Biofilms/growth & development; Biological Evolution; Clinical Trials as Topic; Complementary Therapies/methods; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria/growth & development; Gram-Negative Bacteria/virology; Gram-Positive Bacteria/growth & development; Gram-Positive Bacteria/virology; Humans; Microbial Interactions | |||
|- class="tableEdit_footer" | |||
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.183594.M53a64407c21b6&page=183594&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> || | |||
|} | |||
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.183594.M53a64407c21b6--> | |||
==Significance {{HelpIcon|Help:Literature}} == | |||
{{LitSignificance}} | |||
== Useful Materials and Methods {{HelpIcon|Help:Literature}}== | |||
{{LitMaterials}} | |||
==Annotations {{HelpIcon|Help:Literature}}== | |||
<annotationlinks/> | |||
==EcoliWiki Links {{HelpIcon|Help:Literature}} == | |||
{{LitLinks}} | |||
==See also== | |||
==References== | |||
{{RefHelp}} | |||
<references/> | |||
Latest revision as of 02:48, 22 June 2014
| Citation |
Burrowes, B, Harper, DR, Anderson, J, McConville, M and Enright, MC (2011) Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti Infect Ther 9:775-85 |
|---|---|
| Abstract |
The use of bacteriophages (phages) to treat bacterial infections, known as phage therapy, has a history substantially longer than that of antibiotics, yet these drugs have been the treatment of choice in the West for over 60 years owing to efficacy, low toxicity and ease of production. Bacteria are becoming increasingly resistant to antibiotics while efforts to discover new agents have drastically reduced. Phages have co-evolved with their hosts over billions of years and have acquired mechanisms to counter bacterial defences such as extracellular biofilm production, which severely reduces the effectiveness of conventional antibiotics. Recent animal and human trials show phages to be safe, well-tolerated agents with a bright future as an alternative to chemical agents. |
| Links |
PubMed Online version:10.1586/eri.11.90 |
| Keywords |
Anti-Bacterial Agents/therapeutic use; Bacterial Infections/microbiology; Bacterial Infections/therapy; Bacteriophages/pathogenicity; Biofilms/drug effects; Biofilms/growth & development; Biological Evolution; Clinical Trials as Topic; Complementary Therapies/methods; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria/growth & development; Gram-Negative Bacteria/virology; Gram-Positive Bacteria/growth & development; Gram-Positive Bacteria/virology; Humans; Microbial Interactions |
| edit table |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
<annotationlinks/>
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
See also
References
See Help:References for how to manage references in EcoliWiki.